[1]陈淑平,张 苗,王丽芳.蒲公英联合四联方案治疗脾胃湿热型幽门螺旋杆菌感染相关性胃炎的疗效[J].医学信息,2023,36(13):107-110.[doi:10.3969/j.issn.1006-1959.2023.13.021]
 CHEN Shu-ping,ZHANG Miao,WANG Li-fang.Efficacy of Dandelion Combined with Quadruple Regimen in the Treatment of Helicobacter Pylori Infection-related Gastritis of Spleen-stomach Damp-heat Type[J].Journal of Medical Information,2023,36(13):107-110.[doi:10.3969/j.issn.1006-1959.2023.13.021]
点击复制

蒲公英联合四联方案治疗脾胃湿热型幽门螺旋杆菌感染相关性胃炎的疗效()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年13期
页码:
107-110
栏目:
论著
出版日期:
2023-07-01

文章信息/Info

Title:
Efficacy of Dandelion Combined with Quadruple Regimen in the Treatment of Helicobacter Pylori Infection-related Gastritis of Spleen-stomach Damp-heat Type
文章编号:
1006-1959(2023)13-0107-04
作者:
陈淑平张 苗王丽芳
(上饶市广信区人民医院消化内科1,药剂科2,江西 上饶 334100)
Author(s):
CHEN Shu-pingZHANG MiaoWANG Li-fang
(Department of Gastroenterology,Shangrao Guangxin District People’s Hospital,Shangrao 334100,Jiangxi,China)
关键词:
幽门螺旋杆菌胃炎四联方案蒲公英脾胃湿热型
Keywords:
Helicobacter pyloriGastritisQuadruple schemeDandelionSpleen-stomach damp-heat type
分类号:
R259
DOI:
10.3969/j.issn.1006-1959.2023.13.021
文献标志码:
A
摘要:
目的 探究蒲公英联合四联方案治疗脾胃湿热型幽门螺旋杆菌(Hp)相关性胃炎的疗效。方法 选取2022年7月-2023年1月上饶市广信区人民医院收治的120例脾胃湿热型Hp相关性胃炎患者为研究对象,按照随机数字表法分为对照组与治疗组,各60例。对照组行四联方案治疗(艾司奥美拉唑+阿莫西林+呋喃唑酮+果胶铋),治疗组则在对照组基础上联合蒲公英治疗,比较两组临床疗效、Hp根除率、中医症状积分、不良反应发生率。结果 治疗组治疗总有效率为95.00%,高于对照组的83.33%(P<0.05);治疗组Hp根除率为96.67%,高于对照组的86.67%(P<0.05);两组治疗后中医症状积分(主症、次症、总分)小于治疗前,且治疗组小于对照组(P<0.05);治疗组不良反应发生率为3.33%,小于对照组的15.00%(P<0.05)。结论 蒲公英联合四联方案治疗脾胃湿热型Hp相关性胃炎的疗效肯定,可提高患者Hp根除率,改善其中医症状积分,减少药物不良反应。
Abstract:
Objective To explore the efficacy of dandelion combined with quadruple regimen in the treatment of Helicobacter pylori (Hp)-related gastritis of spleen-stomach damp-heat type.Methods A total of 120 patients with Hp-associated gastritis of spleen-stomach damp-heat type admitted to Shangrao Guangxin District People’s Hospital from July 2022 to January 2023 were selected as the research objects. According to the random number table method, they were divided into control group and treatment group, with 60 patients in each group. The control group was treated with quadruple regimen (esomeprazole+amoxicillin+furazolidone+bismuth pectin), while the treatment group was treated with dandelion on the basis of the control group. The clinical efficacy, Hp eradication rate, TCM symptom score and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the treatment group was 95.00%, which was higher than 83.33% in the control group (P<0.05). The eradication rate of Hp in the treatment group was 96.67%, which was higher than 86.67% in the control group (P<0.05). After treatment, the scores of TCM symptoms (main symptoms, secondary symptoms and total scores) in the two groups were lower than those before treatment, and those in the treatment group were lower than the control group (P<0.05). The incidence of adverse reactions in the treatment group was 3.33%, which was lower than 15.00% in the control group (P<0.05).Conclusion Dandelion combined with quadruple regimen is effective in the treatment of Hp-related gastritis of spleen-stomach damp-heat type, which can improve the eradication effect of Hp, improve the score of TCM symptoms and reduce adverse drug reactions.

参考文献/References:

[1]康影,刘昊,董笑一,等.茵连和胃颗粒联合四联疗法治疗Hp相关性胃炎的疗效分析[J].中国中西医结合消化杂志,2022,30(11):765-768.[2]杨小红,杨海涛,刘超,等.含阿莫西林克拉维酸钾的铋剂四联方案治疗幽门螺杆菌感染致慢性胃炎的有效性及安全性观察[J].药物评价研究,2022,45(9):1863-1869.[3]中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组,全国幽门螺杆菌研究协作组,刘文忠,等.第五次全国幽门螺杆菌感染处理共识报告[J].中华消化杂志,2017,37(6):364-378.[4]刘玲玲,营大礼,张会珍.荆花胃康胶丸联合四联疗法在幽门螺杆菌感染患者中的应用效果[J].中国现代医学杂志,2018,28(22):117-121.[5]李兴瑜,王玲玲,胡俊强,等.胃安除幽汤辅助四联疗法治疗幽门螺杆菌相关性胃炎的疗效及对免疫-炎症、肠道菌群调控效应[J].现代消化及介入诊疗,2022,27(1):76-80.[6]白璐,高睿.荜铃胃痛颗粒联合泮托拉唑四联方案对治疗慢性胃炎合并幽门螺杆菌感染患者的疗效及安全性观察[J].贵州医药,2021,45(11):1716-1717.[7]易超,刘海军,杨双.清幽益胃汤联合改良四联疗法治疗脾胃湿热型Hp感染慢性胃炎患者的临床研究[J].浙江中医药大学学报,2021,45(11):1223-1228.[8]李翰嵩,贾纯亮,梁磊,等.蒲公英甾醇通过NOD1/NF-κB通路对Hp相关性胃炎脾胃湿热证小鼠改善作用研究[J].中医药导报,2021,27(11):25-29.[9]中国中西医结合学会消化系统疾病专业委员会. 慢性胃炎中西医结合诊疗共识意见(2011年天津)[J].中国中西医结合杂志,2012,32(6):738-743.[10]张学智,魏玮,蓝宇.成人幽门螺杆菌引起的胃炎中西医协作诊疗专家共识(2020,北京)[J].中医杂志,2020,61(22):2016-2024.[11]胡伏莲,张声生.全国中西医整合治疗幽门螺杆菌相关“病-证”共识[J].胃肠病学和肝病学杂志,2018,27(9):1008-1016.[12]王琴,高栋梁,庞博.四联疗法联合丹半汤治疗Hp感染致慢性非萎缩性胃炎的效果观察[J].贵州医药,2020,44(10):1560-1561.[13]李琴,谭佳安.消幽复胃汤对脾胃湿热型幽门螺旋杆菌耐药性慢性胃炎的治疗作用分析[J].四川中医,2020,38(10):103-106.[14]叶悟,胡晔,沈莹,等.自拟疏肝泄热和胃汤联合四联疗法治疗Hp阳性慢性胃炎的疗效及对Hp根除率的影响[J].四川中医,2020,38(10):106-109.[15]张涛,苏晓兰,张涛,等.气滞胃痛颗粒联合标准四联治疗Hp阳性慢性胃炎患者的临床效果分析[J].中国中西医结合消化杂志,2021,29(8):529-532.[16]谢伟昌,李京伟,刘磊,等.健脾和胃方合“标准四联”治疗幽门螺杆菌阳性慢性非萎缩性胃炎患者的疗效评价[J].中医药信息,2020,37(4):122-125.[17]刘建伟,马永坤,张丽荣.中药汤剂自拟清幽方联合四联疗法治疗幽门螺旋杆菌感染相关性胃炎的疗效研究[J].四川解剖学杂志,2022,30(3):115-117.[18]姜欣,刘丹,韩林,等.荆花胃康胶丸联合四联疗法治疗Hp阳性老年慢性胃炎的临床效果[J].中国医药导报,2020,17(18):155-158.[19]敦泽,刘艳莉,张伊萌,等.清中益胃汤联合四联疗法治疗Hp相关性慢性胃炎脾胃湿热证的临床观察[J].天津中医药,2020,37(6):666-670.[20]周学东,陈艳,林瑞.蒲公英炮制中总黄酮含量变化及对胃炎治疗分析[J].世界中医药,2020,15(23):3612-3616.[21]田华,黄毓娟.蒲公英多糖对幽门螺杆菌相关性胃炎大鼠胃黏膜炎性反应及MAPK/ERK通路的影响[J].现代中西医结合杂志,2019,28(35):3877-3880.[22]李理,尹晓晨,吴媛妮,等.猴头菇和蒲公英对急性胃粘膜损伤辅助保护作用的动物实验研究[J].预防医学情报杂志,2019,35(11):1294-1296,1301.[23]师鹏,邱婷,刘芳.抗幽合剂联合替普瑞酮治疗慢性浅表性胃炎的效果研究[J].山西医药杂志,2019,48(16):2028-2030.[24]李彬龙,和水祥,李颜霞.两种方案根除消化性溃疡和慢性胃炎患者幽门螺杆菌的疗效对比[J].西部医学,2019,31(7):1053-1056.[25]徐艳琴,朱海超,李进,等.不同药物方案治疗幽门螺杆菌阳性慢性胃炎活动期患者的临床疗效及安全性[J].安徽医学,2019,40(3):244-247.[26]张伟,张振榆.丹参合剂联合四联疗法治疗慢性萎缩性胃炎伴幽门螺杆菌感染48例[J].西部中医药,2018,31(10):91-94.

相似文献/References:

[1]邱梦君,郑国荣.大黄、黄连、黄芩联合三联序贯治疗Hp感染的疗效分析[J].医学信息,2018,31(06):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
 QIU Meng-jun,ZHENG Guo-rong.Curative Effect Analysis of Sequential Treatment of Hp Infection by Rhubarb,Coptis Chinensis and Radix Scutellariae[J].Journal of Medical Information,2018,31(13):137.[doi:10.3969/j.issn.1006-1959.2018.06.047]
[2]夏 铭,张正坤,曾海龙,等.四种疗法治疗幽门螺杆菌阳性消化性溃疡疗效分析[J].医学信息,2018,31(11):18.[doi:10.3969/j.issn.1006-1959.2018.11.006]
 XIA Ming,ZHANG Zheng-kun,ZENG Hai-long,et al.Therapeutic Effect of Four Kinds of Therapy on Helicobacter Pylori Positive Peptic Ulcer[J].Journal of Medical Information,2018,31(13):18.[doi:10.3969/j.issn.1006-1959.2018.11.006]
[3]侯拂晓.四联疗法治疗幽门螺旋杆菌相关性十二指肠球炎疗效分析[J].医学信息,2018,31(17):135.[doi:10.3969/j.issn.1006-1959.2018.17.042]
 HOU Fu-xiao.Therapeutic Effect of Quadruple Therapy on Helicobacter pylori Associated Duodenal Inflammation[J].Journal of Medical Information,2018,31(13):135.[doi:10.3969/j.issn.1006-1959.2018.17.042]
[4]陈 鹏,吴 楠,葛俊君,等.地衣芽胞杆菌联合幽门螺旋杆菌补救疗法的临床观察[J].医学信息,2018,31(23):114.[doi:10.3969/j.issn.1006-1959.2018.23.031]
 CHEN Peng,WU Nan,GE Jun-jun,et al.Clinical Observation of Bacillus Licheniformis Combined with H.pylori Salvage Therapy[J].Journal of Medical Information,2018,31(13):114.[doi:10.3969/j.issn.1006-1959.2018.23.031]
[5]谢迎新.复方嗜酸乳杆菌联合常规四联疗法治疗幽门螺旋杆菌感染消化性溃疡的疗效[J].医学信息,2020,33(02):138.[doi:10.3969/j.issn.1006-1959.2020.02.040]
 XIE Ying-xin.Effect of Compound Lactobacillus Acidophilus Combined with Conventional Quadruple Therapy in the Treatment of Peptic Ulcer Caused by Helicobacter Pylori Infection[J].Journal of Medical Information,2020,33(13):138.[doi:10.3969/j.issn.1006-1959.2020.02.040]
[6]关 旭,田 桦,卓 越,等.不同疗程布拉氏酵母菌对四联疗法根除Hp的影响[J].医学信息,2020,33(05):144.[doi:10.3969/j.issn.1006-1959.2020.05.046]
 GUAN Xu,TIAN Hua,ZHUO Yue,et al.Effects of Different Courses of Candida Bratella on the Eradication of Hp by Quadruple Therapy[J].Journal of Medical Information,2020,33(13):144.[doi:10.3969/j.issn.1006-1959.2020.05.046]
[7]罗小洋,刘戈云,熊 欢,等.老年性胃溃疡相关因素临床研究[J].医学信息,2022,35(18):93.[doi:10.3969/j.issn.1006-1959.2022.18.024]
 LUO Xiao-yang,LIU Ge-yun,XIONG Huan,et al.Clinical Study on Related Factors of Senile Gastric Ulcer[J].Journal of Medical Information,2022,35(13):93.[doi:10.3969/j.issn.1006-1959.2022.18.024]
[8]郭月欢,甘惠中.幽门螺旋杆菌感染与非酒精性脂肪肝的相关性研究[J].医学信息,2022,35(08):89.[doi:10.3969/j.issn.1006-1959.2022.08.021]
 GUO Yue-huan,GAN Hui-zhong.Correlation Between Helicobacter Pylori Infection and Nonalcoholic Fatty Liver Disease[J].Journal of Medical Information,2022,35(13):89.[doi:10.3969/j.issn.1006-1959.2022.08.021]
[9]闫静静,韩 怡.幽门螺旋杆菌感染与非酒精性脂肪性肝病的相关性研究[J].医学信息,2023,36(18):114.[doi:10.3969/j.issn.1006-1959.2023.18.021]
 YAN Jing-jing,HAN Yi.Correlation Analysis Between Helicobacter Pylori Infection and Nonalcoholic Fatty Liver Disease[J].Journal of Medical Information,2023,36(13):114.[doi:10.3969/j.issn.1006-1959.2023.18.021]
[10]刘克学.铝碳酸镁联合兰索拉唑治疗幽门螺旋杆菌相关性胃溃疡的临床疗效及安全性[J].医学信息,2023,36(18):140.[doi:10.3969/j.issn.1006-1959.2023.18.027]
 LIU Ke-xue.Clinical Efficacy and Safety of Hydrotalcite Combined with Lansoprazole in the Treatment of Helicobacter Pylori-associated Gastric Ulcer[J].Journal of Medical Information,2023,36(13):140.[doi:10.3969/j.issn.1006-1959.2023.18.027]

更新日期/Last Update: 1900-01-01